Matthew Reiser Patton

Title: Innovations of Matthew Reiser Patton

Introduction

Matthew Reiser Patton is an accomplished inventor based in Somerville, MA (US). He has made significant contributions to the field of biotechnology, particularly in the modulation of beta-catenin functions. With a total of two patents to his name, Patton's work is at the forefront of innovative medical technologies.

Latest Patents

Patton's latest patents focus on agents that modulate beta-catenin functions and methods thereof. Among other things, these patents provide technologies for modulating the functions of beta-catenin. In some embodiments, the patents disclose stapled peptides that interact with beta-catenin. These stapled peptides are designed to interact with beta-catenin at an Axin-binding site. Furthermore, the patents offer compounds, compositions, and methods for preventing and/or treating conditions, disorders, and diseases associated with beta-catenin.

Career Highlights

Matthew Reiser Patton is currently associated with Fog Pharmaceuticals, Inc., where he continues to advance his research and innovations. His work is pivotal in developing new therapeutic strategies that leverage the modulation of beta-catenin.

Collaborations

Patton collaborates with notable colleagues, including Gerard Hilinski and So Youn Shim. Their combined expertise contributes to the innovative environment at Fog Pharmaceuticals, Inc.

Conclusion

Matthew Reiser Patton's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work on beta-catenin modulation has the potential to impact various medical conditions significantly.